FDA 510(k) Clearance Explained: What It Means for AK Medical in the U.S. Market

In international medical device trade, "FDA certified," "FDA registered," and "FDA approved" often get used as if they mean the same thing. Under U.S. regulation, they don't — and the FDA does not issue a blanket "certification" to a manufacturer simply because an establishment is registered.

AK Medical's public FDA record shows the A3 Total Knee System, cleared under 510(k) K180493, with an FDA Substantially Equivalent (SE) decision issued June 22, 2018. That precision matters: FDA clearance applies to a defined device and scope, not to a company, a technology platform, or an entire product portfolio.

What 510(k) clearance means

The 510(k) pathway is one of the principal U.S. premarket routes for medical devices. To clear a device, a manufacturer must show FDA that it is substantially equivalent to a legally marketed predicate — considering intended use, technological characteristics, and whether any differences raise new safety or effectiveness questions.

A cleared device can be marketed in the U.S. within the scope of that clearance, subject to other applicable requirements. But 510(k) clearance is not an FDA finding that a device is superior to competitors, will produce a specific clinical outcome, or extends clearance to every other product a manufacturer makes.

One clearance doesn't cover a whole portfolio

K180493 covers the A3 Total Knee System configuration described in that specific FDA submission — it should not be assumed to extend to other configurations, other knee systems, or other AK Medical technologies such as 3D-printed or hip implants. The reliable way to verify any device is at the product level: trade name → model/configuration → intended use → regulatory classification → the applicable 510(k), PMA, De Novo, or exemption → current labeling.

Clearance is one part of a longer compliance chain

U.S. medical device regulation continues well past premarket review. A simplified lifecycle looks like: premarket review → market authorization → establishment registration and device listing → quality management system → labeling and UDI → import and distribution compliance → complaint handling and postmarket surveillance → change control.

A meaningful recent change: FDA's Quality Management System Regulation (QMSR), effective February 2, 2026, amended 21 CFR Part 820 to incorporate ISO 13485:2016 by reference into the U.S. quality framework. For hospitals and distributors, that means supplier evaluation should look beyond "do you have ISO 13485?" to design controls, risk management, supplier controls, CAPA, and inspection readiness.

Foreign manufacturers supplying the U.S. market, including AK Medical, must also register with FDA and designate a U.S. Agent — a communication point between FDA and the manufacturer, distinct from product authorization or distribution rights.

How to verify a device for the U.S. market

1. Identify the exact product — trade name, model, configuration, catalog number.
2. Identify the applicable regulatory pathway (510(k), PMA, De Novo, or exemption).
3. Confirm the scope of authorization matches the supplied configuration and intended use.
4. Confirm establishment registration and device listing.
5. Match UDI, labeling, and IFU to the supplied product.
6. Evaluate the manufacturer's ongoing quality and postmarket system.

That six-step chain gives hospitals, distributors, and GPOs far more regulatory confidence than a single yes/no question about "FDA certification."

The bottom line

For AK Medical, the A3 Total Knee System under 510(k) K180493 is a publicly verifiable example of FDA clearance. The broader principle applies across the industry: regulatory status belongs to the specific device, not to the brand as a whole.

Learn more about the A3 Primary Total Knee System in our product catalogue.

References

1. U.S. FDA 510(k) premarket notification K180493 — A3 Total Knee System, Beijing AK Medical Co., Ltd., decision date 22 June 2018. FDA 510(k) database · clearance letter (PDF)

This article is intended for general regulatory education and does not constitute legal advice. It does not replace FDA databases, current U.S. Instructions for Use, labeling, or applicable regulatory documentation. Product-specific status should be verified before procurement, promotion, importation, or clinical use.